Related Experiment Videos
[New plasmid resistance of Staphylococcus aureus to aminosides (gentamicin, tobramycin, amikacin]
La Nouvelle Presse Medicale
|November 1, 1976
Abstract:
Recently, strains of Staphylococcus aureus resistant to gentamicin, tobramycin and amikacin have been discovered in several hospitals in France. These new resistances, of two different types, are of plasmid origin and of enzyme mechanism. This study describes their current incidence.
Insights
New strains of Staphylococcus aureus resistant to key antibiotics like gentamicin have emerged in French hospitals. These resistances are linked to plasmid origin and enzyme mechanisms, and their current prevalence is detailed.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Context:
- Emergence of multidrug-resistant bacteria in healthcare settings.
- Increasing prevalence of gentamicin, tobramycin, and amikacin resistance in Staphylococcus aureus.
- Identification of novel resistance mechanisms in clinical isolates.
Purpose:
- To investigate the incidence and characteristics of new antibiotic resistances in Staphylococcus aureus.
- To describe the plasmid and enzyme-based mechanisms underlying these resistances.
- To provide an overview of the current epidemiological situation in France.
Summary:
- Recent discovery of Staphylococcus aureus strains exhibiting resistance to gentamicin, tobramycin, and amikacin in French hospitals.
- Two distinct resistance types identified: plasmid-mediated and enzyme-based.
- Study details the current incidence and nature of these emerging resistances.
Impact:
- Highlights the growing threat of antibiotic resistance in clinical settings.
- Informs infection control strategies and antibiotic stewardship programs.
- Provides crucial data for public health surveillance of resistant pathogens.